Lihua H. Wang
246 Xuefu Road
Harbin, 150081, China
Harbin, 150081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 129 publications
Infarct growth rate and tenecteplase benefit in ischemic stroke at 4.5 to 24 h without thrombectomy-A secondary analysis of the TRACE-III randomized trial.
Journal: International journal of stroke : official journal of the International Stroke Society
Published: April 07, 2026
Disruption of intestinal barrier and immune homeostasis links gut microbiota dysbiosis to aggravated experimental autoimmune myasthenia gravis.
Journal: Frontiers in cellular and infection microbiology
Published: February 18, 2026
Circular RNA circNUP214 serves as a microRNA-31 sponge to promote the progression of myasthenia gravis through NFAT5.
Journal: Frontiers in neurology
Published: February 10, 2026
Clinical benefit of tenecteplase despite failed recanalization in late-window ischemic stroke: a post hoc analysis of the TRACE-3 trial.
Journal: BMC medicine
Published: December 23, 2025
Hsa_circ_0065149 mediates the ceRNA network pathway: Research on the mechanism regulating myasthenia gravis.
Journal: Journal of molecular neuroscience : MN
Published: December 19, 2025
Quantitative Gait Analysis Reveals Distinct Patterns Associated With Pyramidal Involvement in Amyotrophic Lateral Sclerosis: A Cross-Sectional Study.
Journal: Brain and behavior
Published: November 30, 2025
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial.
Journal: Lancet (London, England)
Published: November 06, 2025
Liraglutide in Acute Minor Ischemic Stroke or High-Risk Transient Ischemic Attack With Type 2 Diabetes: The LAMP Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: November 03, 2025
Hsa_circ_0000313/miR-1224-3p/MKNK2 Axis Modulates CD4+ T Cells by Activating p38 MAPK Signaling in Myasthenia Gravis.
Journal: Mediators of inflammation
Published: October 22, 2025
Corrigendum to A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study Lancet Reg Health West Pac (2023) 38: 100846.
Journal: The Lancet regional health. Western Pacific
Published: October 13, 2025
From Limited Samples to Mechanistic Insights: Exploratory Identification and Functional Validation of a hsa_circ_0062400/hsa_circ_0002397-miR-338-3p-NRP1 Axis in Myasthenia Gravis
Journal: Endocrine, metabolic & immune disorders drug targets
Published: September 23, 2025
Last Updated: 09/26/2026